Evince Clinical Assessments
 
DAPPER-3 BENEFITS
Dimensional Assessment for Patient
Placement Engagement & Retention-3
  • Practical treatment planning based on the ASAM Criteria.
  • Comprehensive documentation of patient needs and strengths within each of the six ASAM dimensions.
  • Quantitative ratings of problem severity.
  • Document multiple assessments during an episode of care on one form.
by
Norman G. Hoffmann, Ph.D.
David Mee-Lee, M.D.
Gerald D. Shulman, M.A., M.A.C., FACATA
 
The DAPPER-3 is a comprehensive assessment tool designed for documenting areas of strength, needs, or concern within each of the six dimensions of the ASAM Criteria. The DAPPER-3 guides the clinician by providing ratings of key constructs on each of the six assessment dimensions. The numeric ratings provide a means of comparing impressions among clinicians and assessing improvement or outcomes it in repeated assessments. The DAPPER-3 is designed for use in the initial assessment and in monitoring progress during treatment. The ratings provide a semi-structured guide for each assessment so that key components of each of the assessment dimensions are covered and monitored.
APPLICATIONS: The DAPPER-3 is designed to assist in guiding assessment, providing problem severity indications, and providing documentation of improvement and treatment outcomes. It provides comprehensive yet easy-to-use documentation for clinical decisions to support reimbursement, and can clarify communication between clinicians and utilization reviewers. Each form can be used for up to six assessments per individual.
 
ORDERING: The DAPPER-3 forms are distributed by The Change Companies and can be ordered by calling the 888-889-8866 or 775-885-0643. Additional information can be obtained at www.changecompanies.net.
 
TIME REQUIREMENTS: The time to complete the DAPPER-3 depends on the data available and interviewing required to complete the ratings. If used with an instrument such as the CAAPE-5, only 20-30 minutes should be required. If used instead of a biopsychosocial time interview, about 45 -50 minutes may be required. Completion of the DAPPER-3 should make the overall treatment planning and placement process more time efficient as well as thorough.
 
DEVELOPMENT: Developed by nationally and internationally recognized experts in addictions treatment: David Mee-Lee, M.D., Gerald D. Shulman, M.A., M.A.C., FACATA, and Norman G. Hoffmann, Ph.D.
 

COPYRIGHT: The DAPPER-3 is copyrighted and may not be adapted or reproduced. To do so is a violation of copyright law and constitutes unethical conduct.

 
  The DAPPER-3 is distributed by
The Change Companies
5221 Sigstrom Dr., Carson City, NV 89706
Voice: 888-889-8866 Fax: 775-885-0643
www.changecompanies.net

 
2016 Evince Clinical Assessments